SELLAS Life Sciences SLS
NASDAQ SLS
$11.98 +0.47 (+4.13%)
As of: Sep 30, 2026 · 11:29 AM EDT

SELLAS Life Sciences (SLS) Receivables - Other (2012 - 2018)

Updated

SELLAS Life Sciences (SLS) recorded Receivables - Other of $6.6 million in Q3 2018, compared with $500,000 a year earlier.

Analysis

SELLAS Life Sciences (SLS) Receivables - Other (2012 - 2018) Analysis & Trends

At the end of FY2015, SELLAS Life Sciences reported Receivables - Other of $21.7 million.

  • Annual Receivables - Other has a three-year compound annual growth rate of 342.8% (FY2012 to FY2015).
  • Across earlier years, Receivables - Other came in at $250,000 in FY2012.
  • The Q3 2018 figure is the highest quarterly Receivables - Other since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 6.60 Mn
Sep 30, 2017 500,000.00
Mar 31, 2016 1.70 Mn
Dec 31, 2015 21.70 Mn
Dec 31, 2012 250,000.00
API Access

SELLAS Life Sciences Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SLS&period=max&api_key=YOUR_API_KEY